RALOXIFENE BIOGARAN 60 mg, comprimé pelliculé — plaquette(s) PVC polyéthylène PVDC aluminium de 28 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400941994708 -
CIP7
4199470 -
CIS
67760715
What the source publishes
- Holder
- BIOGARAN
- Active ingredients
- CHLORHYDRATE DE RALOXIFÈNE, RALOXIFÈNE
- Form
- comprimé pelliculé
- Package
- plaquette(s) PVC polyéthylène PVDC aluminium de 28 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2011-09-14
- Prescription
- Prescription or restricted
Names this record is found by
- RALOXIFENE BIOGARAN 60 mg, comprimé pelliculé — plaquette(s) PVC polyéthylène PVDC aluminium de 28 comprimé(s)
- RALOXIFENE BIOGARAN 60 mg, comprimé pelliculé
- CHLORHYDRATE DE RALOXIFÈNE
- RALOXIFÈNE
Complete source data
{
"cis": "67760715",
"cip7": "4199470",
"form": "comprimé pelliculé",
"name": "RALOXIFENE BIOGARAN 60 mg, comprimé pelliculé — plaquette(s) PVC polyéthylène PVDC aluminium de 28 comprimé(s)",
"cip13": "3400941994708",
"holder": "BIOGARAN",
"routes": [
"orale"
],
"holders": [
"BIOGARAN"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "11.92",
"authorisedOn": "2011-09-14",
"compositions": [
{
"name": "CHLORHYDRATE DE RALOXIFÈNE",
"nature": "SA",
"strength": "60 mg",
"linkageNumber": "1",
"substanceCode": "79270",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "RALOXIFÈNE",
"nature": "FT",
"strength": "56,00 mg",
"linkageNumber": "1",
"substanceCode": "93678",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "10.90",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "RALOXIFENE BIOGARAN 60 mg, comprimé pelliculé",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-18",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) PVC polyéthylène PVDC aluminium de 28 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65%"
],
"marketingDeclaredOn": "2012-12-28",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE DE RALOXIFÈNE",
"RALOXIFÈNE"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Prévention et traitement de l'ostéoporose postménopausique du rachis, pour réduire le risque de fractures vertébrales, chez les femmes âgées de moins de 70 ans, sans facteur de risque veineux et avec apport de calcium<br> ; JOURNAL OFFICIEL ; 17/05/01",
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400941994708"